SURESH SRINIVASAN: Open Payments
NPI 1346672268 · STEUBENVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$915 in 49 payments from 9 companies in 2025. Trend: 2023 $1,998 · 2024 $2,232 · 2025 $915
Food & beverage: $915
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 24 | $350 |
| Abbott Laboratories | 4 | $195 |
| Collegium Pharmaceutical, Inc. | 12 | $161 |
| TerSera Therapeutics LLC | 4 | $118 |
| Averitas Pharma Inc. | 1 | $27 |
| Globus Medical, Inc. | 1 | $25 |
| Forte Bio-Pharma LLC | 1 | $17 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| SPR Therapeutics, Inc | 1 | $5 |
Products named: Intracept, PROCLAIM, Prialt, Belbuca, WaveWriter Alpha Prime 16, General - Pain Management, XTAMPZA, QUTENZA.
Industry payments across OH — which companies pay providers there.
